India to Hong Kong: Mycophenolate Export Trade Route
India has recorded 3 verified shipments of Mycophenolate exported to Hong Kong, representing a combined trade value of $3.5M USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $1.2M USD. The leading Indian exporter is INTAS PHARMACEUTICALS LIMITED, which accounts for 99% of total export value with 2 shipments worth $3.5M USD. On the buying side, I & C (HONGKONG) LIMITED is the largest importer in Hong Kong with $3.5M USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Hong Kong Mycophenolate corridor is one of India's established pharmaceutical export routes, with 3 shipments documented worth a combined $3.5M USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 99% of all export value, reflecting the consolidated nature of India's mycophenolate manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $1.2M USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (0%) and air (100%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October-December, with an average transit time of 7 days port-to-port. The route has recorded an annual growth rate of 5%, placing it at rank #5 among India's top mycophenolate export destinations globally.
On the import side, key buyers of Indian mycophenolate in Hong Kong include I & C (HONGKONG) LIMITED, TO STANDARD CHARTERED , PHARMASON COMPANY LIMITED. I & C (HONGKONG) LIMITED is the single largest importer with 1 shipments valued at $3.5M USD.
